Protein profiling identified dissociations between growth hormone-mediated longitudinal growth and bone mineralization in short prepubertal children

Nilsson, 2005, Endocrine regulation of the growth plate, Horm Res, 64, 157, 10.1159/000088791 Ohlsson, 1998, Growth hormone and bone, Endocr Rev, 19, 55, 10.1210/er.19.1.55 Saggese, 1996, The effect of long-term growth hormone (GH) treatment on bone mineral density in children with GH deficiency. Role of GH in the attainment of peak bone mass, J Clin Endocrinol Metab, 81, 3077, 10.1210/jc.81.8.3077 Lanes, 2000, Growth velocity, final height and bone mineral metabolism of short children treated long term with growth hormone, Curr Pharm Biotechnol, 1, 33, 10.2174/1389201003378997 Albertsson-Wikland, 2000, Validated multivariate models predicting the growth response to GH treatment in individual short children with a broad range in GH secretion capacities, Pediatr Res, 48, 475, 10.1203/00006450-200010000-00010 Dahlgren, 2007, Models predicting the growth response to growth hormone treatment in short children independent of GH status, birth size and gestational age, BMC Med Inform Decis Mak, 7, 40, 10.1186/1472-6947-7-40 Kristrom, 2009, Growth hormone (GH) dosing during catch-up growth guided by individual responsiveness decreases growth response variability in prepubertal children with GH deficiency or idiopathic short stature, J Clin Endocrinol Metab, 94, 483, 10.1210/jc.2008-1503 Wikipedia.org: DXA 2009 Website: http://www.en.wikipedia.org/wiki/DXA. Issaq, 2002, The SELDI-TOF MS approach to proteomics: protein profiling and biomarker identification, Biochem Biophys Res Commun, 292, 587, 10.1006/bbrc.2002.6678 Andersson, 2009, Proteins related to lipoprotein profile were identified using a pharmaco-proteomic approach as markers for growth response to growth hormone (GH) treatment in short prepubertal children, Proteome Sci, 7, 40, 10.1186/1477-5956-7-40 Kristrom, 2009, The first-year growth response to growth hormone treatment predicts the long-term prepubertal growth response in children, BMC Med Inform Decis Mak, 9, 1, 10.1186/1472-6947-9-1 Jansson, 1997, Growth hormone (GH) assays: influence of standard preparations, GH isoforms, assay characteristics, and GH-binding protein, Clin Chem, 43, 950, 10.1093/clinchem/43.6.950 Karlberg, 1989, On the construction of the infancy–childhood–puberty growth standard, Acta Paediatr Scand Suppl, 356, 26, 10.1111/j.1651-2227.1989.tb11237.x Albertsson-Wikland, 2002, Swedish population-based longitudinal reference values from birth to 18years of age for height, weight and head circumference, Acta Paediatr, 91, 739, 10.1111/j.1651-2227.2002.tb03322.x Ioannidou, 2003, Pencil-beam versus fan-beam dual-energy X-ray absorptiometry comparisons across four systems: appendicular lean soft tissue, Acta Diabetol, 40, S83, 10.1007/s00592-003-0034-x Margulies, 2005, Reproducibility of pediatric whole body bone and body composition measures by dual-energy X-ray absorptiometry using the GE Lunar Prodigy, J Clin Densitom, 8, 298, 10.1385/JCD:8:3:298 Kay, 2008, Enrichment of low molecular weight serum proteins using acetonitrile precipitation for mass spectrometry based proteomic analysis, Rapid Commun Mass Spectrom, 22, 3255, 10.1002/rcm.3729 Hellgren, 2008, A proteomic approach identified growth hormone dependent nutrition markers in children with idiopathic short stature, Proteome Sci, 6, 35, 10.1186/1477-5956-6-35 Shevchenko, 2006, In-gel digestion for mass spectrometric characterization of proteins and proteomes, Nat Protoc, 1, 2856, 10.1038/nprot.2006.468 Draper, 1998, 307 Efron, 2004, Least angle regression, Ann Statist, 32, 407, 10.1214/009053604000000067 Tibshirani, 1996, Regression shrinkage and selection via the lasso, J Roy Stat Soc Ser B, 58, 267288 Mallat, 1993, Matching pursuit with time-frequency dictionaries, IEEE Trans Signal Process, 41, 3397, 10.1109/78.258082 SparseLab: 2009 Website: http://www.sparselab.stanford.edu/. Baroncelli, 1998, Measurement of volumetric bone mineral density accurately determines degree of lumbar undermineralization in children with growth hormone deficiency, J Clin Endocrinol Metab, 83, 3150, 10.1210/jc.83.9.3150 Molgaard, 1997, Whole body bone mineral content in healthy children and adolescents, Arch Dis Child, 76, 9, 10.1136/adc.76.1.9 Leonard, 2004, Interpretation of whole body dual energy X-ray absorptiometry measures in children: comparison with peripheral quantitative computed tomography, Bone, 34, 1044, 10.1016/j.bone.2003.12.003 Carter, 1992, New approaches for interpreting projected bone densitometry data, J Bone Miner Res, 7, 137, 10.1002/jbmr.5650070204 Gordon, 2008, Dual energy X-ray absorptiometry interpretation and reporting in children and adolescents: the 2007 ISCD Pediatric Official Positions, J Clin Densitom, 11, 43, 10.1016/j.jocd.2007.12.005 Ali, 2007, Growth hormone therapy improves bone mineral density in children with cerebral palsy: a preliminary pilot study, J Clin Endocrinol Metab, 92, 932, 10.1210/jc.2006-0385 Sopher, 2001, Prepubertal girls with premature adrenarche have greater bone mineral content and density than controls, J Clin Endocrinol Metab, 86, 5269, 10.1210/jc.86.11.5269 Zemel, 2010, Height adjustment in assessing dual energy X-ray absorptiometry measurements of bone mass and density in children, J Clin Endocrinol Metab, 95, 1265, 10.1210/jc.2009-2057 Lanes, 2002, The effect of short- and long-term growth hormone treatment on bone mineral density and bone metabolism of prepubertal children with idiopathic short stature: a 3-year study, Clin Endocrinol (Oxf), 57, 725, 10.1046/j.1365-2265.2002.01614.x Baroncelli, 2003, Acquisition of bone mass in normal individuals and in patients with growth hormone deficiency, J Pediatr Endocrinol Metab, 16, 327 van der Sluis, 2002, Long-term effects of growth hormone therapy on bone mineral density, body composition, and serum lipid levels in growth hormone deficient children: a 6-year follow-up study, Horm Res, 58, 207, 10.1159/000066262 Deterding, 2002, Separation and characterization of human high-density apolipoproteins using a nonaqueous modifier in capillary electrophoresis-mass spectrometry, Electrophoresis, 23, 2296, 10.1002/1522-2683(200207)23:14<2296::AID-ELPS2296>3.0.CO;2-I Lackner, 1985, Isoforms of apolipoprotein A-II in human plasma and thoracic duct lymph. Identification of proapolipoprotein A-II and sialic acid-containing isoforms, J Biol Chem, 260, 703, 10.1016/S0021-9258(20)71153-1 Schmitz, 1983, Isoproteins of human apolipoprotein A-II: isolation and characterization, J Lipid Res, 24, 1021, 10.1016/S0022-2275(20)37916-5 Niederkofler, 2003, Novel mass spectrometric immunoassays for the rapid structural characterization of plasma apolipoproteins, J Lipid Res, 44, 630, 10.1194/jlr.D200034-JLR200 Malik, 2005, Serum levels of an isoform of apolipoprotein A-II as a potential marker for prostate cancer, Clin Cancer Res, 11, 1073, 10.1158/1078-0432.1073.11.3 Shachter, 2001, Apolipoproteins C-I and C-III as important modulators of lipoprotein metabolism, Curr Opin Lipidol, 12, 297, 10.1097/00041433-200106000-00009 Sousa, 2000, Transthyretin in high density lipoproteins: association with apolipoprotein A-I, J Lipid Res, 41, 58, 10.1016/S0022-2275(20)32074-5 Yamada, 1996, Characterization of serum amyloid A4 as a plasma apolipoprotein, Clin Chim Acta, 251, 105, 10.1016/0009-8981(96)06296-1 Florentin, 2008, Multiple actions of high-density lipoprotein, Curr Opin Cardiol, 23, 370, 10.1097/HCO.0b013e3283043806 Sackmann-Sala, 2009, Activation of the GH/IGF-1 axis by CJC-1295, a long-acting GHRH analog, results in serum protein profile changes in normal adult subjects, Growth Horm IGF Res, 19, 471, 10.1016/j.ghir.2009.03.001 Lanes, 2006, Growth hormone deficiency, low levels of adiponectin, and unfavorable plasma lipid and lipoproteins, J Pediatr, 149, 324, 10.1016/j.jpeds.2006.05.010 Schaefer, 1994, Lipids and apolipoproteins in growth hormone-deficient children during treatment, Metabolism, 43, 1457, 10.1016/0026-0495(94)90001-9 Blackett, 1982, Growth hormone in the regulation of hyperlipidemia, Metabolism, 31, 117, 10.1016/0026-0495(82)90121-4 Oscarsson, 1994, Serum lipoproteins in acromegaly before and 6–15months after transsphenoidal adenomectomy, Clin Endocrinol (Oxf), 41, 603, 10.1111/j.1365-2265.1994.tb01825.x Parkinson, 2002, Serum lipoprotein changes following IGF-I normalization using a growth hormone receptor antagonist in acromegaly, Clin Endocrinol (Oxf), 56, 303, 10.1046/j.1365-2265.2002.01460.x Dundar, 2007, Bone metabolism and mineral density in patients with beta-thalassemia major, Saudi Med J, 28, 1425 Salama, 2006, Unbalanced bone turnover in children with beta-thalassemia, Hematology, 11, 197, 10.1080/10245330600702851 Karimi, 2004, Short stature in beta-thalassemia minor subjects, Med Sci Monit, 10, CR603 Lahuna, 1997, Expression of hepatocyte nuclear factor 6 in rat liver is sex-dependent and regulated by growth hormone, Proc Natl Acad Sci USA, 94, 12309, 10.1073/pnas.94.23.12309 Samadani, 1996, The transcriptional activator hepatocyte nuclear factor 6 regulates liver gene expression, Mol Cell Biol, 16, 6273, 10.1128/MCB.16.11.6273 Connolly, 2003, Recombinant human growth hormone increases thyroid hormone-binding sites in recovering severely burned children, Shock, 19, 399, 10.1097/01.shk.0000051758.08171.bc Luo, 2004, Effects of recombinant human growth hormone on remnant liver after hepatectomy in hepatocellular carcinoma with cirrhosis, World J Gastroenterol, 10, 1292, 10.3748/wjg.v10.i9.1292 Yamada, 2001, Further characterization of serum amyloid A4 as a minor acute phase reactant and a possible nutritional marker, Clin Chem Lab Med, 39, 7, 10.1515/CCLM.2001.003 Mugavin, 2008, Multidimensional scaling: a brief overview, Nurs Res, 57, 64, 10.1097/01.NNR.0000280659.88760.7c Jackson, 1974, The primary structure of apolopoprotein-serine, J Biol Chem, 249, 5308, 10.1016/S0021-9258(19)42365-X Jin, 2005, Direct targeting of human plasma for matrix-assisted laser desorption/ionization and analysis of plasma proteins by time of flight-mass spectrometry, Electrophoresis, 26, 2823, 10.1002/elps.200410421 Farwig, 2005, Novel truncated isoforms of constitutive serum amyloid A detected by MALDI mass spectrometry, Biochem Biophys Res Commun, 332, 352, 10.1016/j.bbrc.2005.04.129